Filing Details

Accession Number:
0001133416-24-000044
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-20 13:55:08
Reporting Period:
2024-06-20
Accepted Time:
2024-06-20 13:55:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1133416 Galectin Therapeutics Inc GALT Pharmaceutical Preparations (2834) 043562325
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1522478 D Kevin Freeman C/O Galectin Therapeutics Inc.
4960 Peachtree Industrial Blvd., Ste 240
Norcross GA 30071
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-06-20 2,500 $2.38 28,469 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 75,000 Indirect By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC
Common Stock 18,063 Indirect IRA
Footnotes
  1. Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.